• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨形态发生蛋白在强直性脊柱炎中的作用。

The role of bone morphogenetic proteins in ankylosing spondylitis.

机构信息

Arthritis Research Unit, Laboratory for Skeletal Development and Joint Disorders, K.U. Leuven, Leuven, Belgium.

出版信息

Ther Adv Musculoskelet Dis. 2012 Aug;4(4):293-9. doi: 10.1177/1759720X12444175.

DOI:10.1177/1759720X12444175
PMID:22859928
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3403253/
Abstract

Ankylosing spondylitis (AS), the best-known form of spondyloarthritis (SpA), is a remodelling arthritis characterized by chronic inflammation and bone formation. Ankylosis of the axial skeleton and sacroiliac joints leads to an impairment of spinal mobility, progressive spinal fusion and an increased risk of spinal fractures. The nature of the relationship between inflammation and new bone formation in AS has been controversial and questions remain as to whether there is a direct relationship between inflammation and new bone formation. Like others, we have hypothesized that the molecular pathways underlying ankylosis recapitulate the process of endochondral bone formation and that bone morphogenetic proteins (BMPs) play a key role in this process in AS. Furthermore, we discuss the entheseal stress hypothesis, which proposes that inflammation and ankylosis are linked but largely independent processes, and consider observations from mouse models and other human diseases which also imply that biomechanical factors contribute to the pathogenesis of AS. As current therapeutics, such as tumour necrosis factor inhibitors do not impede disease progression and ankylosis in AS, it is the pathways discussed in this review that are the now the focus for the identification of future drug targets.

摘要

强直性脊柱炎(AS),即最常见的脊柱关节炎(SpA)形式,是一种以慢性炎症和骨形成为特征的骨改建关节炎。轴性骨骼和骶髂关节的强直会导致脊柱活动度受损、进行性脊柱融合以及脊柱骨折风险增加。AS 中炎症和新骨形成之间的关系性质一直存在争议,并且仍存在炎症和新骨形成之间是否存在直接关系的问题。和其他人一样,我们假设,在脊柱强直中,新骨形成的分子途径再现了软骨内骨形成的过程,并且骨形态发生蛋白(BMPs)在该过程中发挥关键作用。此外,我们还讨论了腱附着点应激假说,该假说提出炎症和强直是相互关联但在很大程度上是独立的过程,并考虑了来自小鼠模型和其他人类疾病的观察结果,这些结果也表明生物力学因素有助于 AS 的发病机制。由于目前的治疗方法,如肿瘤坏死因子抑制剂并不能阻止 AS 中的疾病进展和强直,因此,正是本综述中讨论的途径成为了确定未来药物靶点的重点。

相似文献

1
The role of bone morphogenetic proteins in ankylosing spondylitis.骨形态发生蛋白在强直性脊柱炎中的作用。
Ther Adv Musculoskelet Dis. 2012 Aug;4(4):293-9. doi: 10.1177/1759720X12444175.
2
Bone Disease in Axial Spondyloarthritis.中轴型脊柱关节炎的骨骼疾病。
Calcif Tissue Int. 2018 May;102(5):547-558. doi: 10.1007/s00223-017-0356-2. Epub 2017 Oct 31.
3
Can we stop progression of ankylosing spondylitis?我们能否阻止强直性脊柱炎的进展?
Best Pract Res Clin Rheumatol. 2010 Jun;24(3):363-71. doi: 10.1016/j.berh.2010.01.005.
4
Ankylosis in ankylosing spondylitis: current concepts.强直性脊柱炎中的关节强直:当前概念
Clin Rheumatol. 2015 Jun;34(6):1003-7. doi: 10.1007/s10067-015-2956-4.
5
Evolving concepts of new bone formation in axial spondyloarthritis: Insights from animal models and human studies.轴性脊柱关节炎中新骨形成概念的演变:动物模型和人类研究的启示。
Best Pract Res Clin Rheumatol. 2017 Dec;31(6):877-886. doi: 10.1016/j.berh.2018.07.007. Epub 2018 Sep 20.
6
Structural progression rate decreases over time on serial radiography and magnetic resonance imaging of sacroiliac joints and spine in a five-year follow-up study of patients with ankylosing spondylitis treated with tumour necrosis factor inhibitor.在一项为期五年的强直性脊柱炎患者肿瘤坏死因子抑制剂治疗的随访研究中,通过骶髂关节和脊柱的连续影像学(X 线和磁共振)发现,结构进展率随时间推移而降低。
Scand J Rheumatol. 2019 May;48(3):185-197. doi: 10.1080/03009742.2018.1506822. Epub 2018 Nov 13.
7
Inhibition of inflammation but not ankylosis by glucocorticoids in mice: further evidence for the entheseal stress hypothesis.糖皮质激素抑制小鼠炎症但不抑制强直:腱附着点应力假说的进一步证据。
Arthritis Res Ther. 2012 Mar 12;14(2):R59. doi: 10.1186/ar3772.
8
Biologic therapies in the spondyloarthritis: new opportunities, new challenges.脊柱关节炎的生物治疗:新机遇,新挑战。
Curr Opin Rheumatol. 2003 Jul;15(4):394-407. doi: 10.1097/00002281-200307000-00005.
9
Bone formation versus bone resorption in ankylosing spondylitis.强直性脊柱炎中的骨形成与骨吸收
Adv Exp Med Biol. 2009;649:114-21. doi: 10.1007/978-1-4419-0298-6_8.
10
Insights into the pathophysiology of ankylosing spondylitis: contributions from animal models.强直性脊柱炎病理生理学的研究进展:动物模型的贡献。
Joint Bone Spine. 2012 May;79(3):243-8. doi: 10.1016/j.jbspin.2011.09.008. Epub 2011 Nov 12.

引用本文的文献

1
Pilot Investigation on Markers of Bone Metabolism, Angiogenesis, and Neuroendocrine Activity as Potential Predictors of Survival of Metastatic Prostate Cancer Patients with Bone Metastases.骨代谢、血管生成和神经内分泌活动标志物作为骨转移前列腺癌患者生存潜在预测指标的初步研究
Int J Mol Sci. 2025 May 13;26(10):4669. doi: 10.3390/ijms26104669.
2
Wnt5a exacerbates pathological bone features and trabecular bone loss in curdlan-injected SKG mice via osteoclast activation.Wnt5a通过激活破骨细胞,加剧了注射凝胶多糖的SKG小鼠的病理性骨特征和小梁骨丢失。
BMB Rep. 2025 Feb;58(2):75-81. doi: 10.5483/BMBRep.2024-0155.
3
Axial Spondyloarthritis: an overview of the disease.轴性脊柱关节炎:疾病概述
Rheumatol Int. 2024 Sep;44(9):1607-1619. doi: 10.1007/s00296-024-05601-9. Epub 2024 Apr 30.
4
Sequence of Events in the Pathogenesis of Axial Spondyloarthritis: A Current Review-2023 SPARTAN Meeting Proceedings.轴性脊柱关节炎发病机制中的事件序列:2023 年 SPARTAN 会议记录的当前综述。
Curr Rheumatol Rep. 2024 Apr;26(4):133-143. doi: 10.1007/s11926-024-01136-x. Epub 2024 Feb 7.
5
The Role of Sclerostin in Rheumatic Diseases: A Review.硬化蛋白在风湿性疾病中的作用:综述
J Clin Med. 2023 Sep 28;12(19):6248. doi: 10.3390/jcm12196248.
6
Osteoimmunology of Spondyloarthritis.脊柱关节炎的骨免疫学。
Int J Mol Sci. 2023 Oct 5;24(19):14924. doi: 10.3390/ijms241914924.
7
Elevated BMPR2 expression amplifies osteoblast differentiation in ankylosing spondylitis.骨形态发生蛋白受体2(BMPR2)表达升高会增强强直性脊柱炎中的成骨细胞分化。
J Rheum Dis. 2023 Oct 1;30(4):243-250. doi: 10.4078/jrd.2023.0024. Epub 2023 Jul 28.
8
Joint together: The etiology and pathogenesis of ankylosing spondylitis.关节相连:强直性脊柱炎的病因和发病机制。
Front Immunol. 2022 Oct 17;13:996103. doi: 10.3389/fimmu.2022.996103. eCollection 2022.
9
A adenosine receptor agonist reduced MMP8 expression in healthy M2-like macrophages but not in macrophages from ankylosing spondylitis patients.一种腺苷受体激动剂可降低健康 M2 样巨噬细胞中 MMP8 的表达,但不能降低强直性脊柱炎患者巨噬细胞中 MMP8 的表达。
BMC Musculoskelet Disord. 2022 Oct 12;23(1):908. doi: 10.1186/s12891-022-05846-0.
10
Tail suspension delays ectopic ossification in proteoglycan-induced ankylosing spondylitis in mice via miR-103/DKK1.尾部悬吊通过miR-103/DKK1延缓蛋白聚糖诱导的小鼠强直性脊柱炎中的异位骨化。
Exp Ther Med. 2021 Sep;22(3):965. doi: 10.3892/etm.2021.10397. Epub 2021 Jul 7.

本文引用的文献

1
High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis.高水平的功能性 Dickkopf-1 可预测强直性脊柱炎患者脊柱融合的形成。
Ann Rheum Dis. 2012 Apr;71(4):572-4. doi: 10.1136/annrheumdis-2011-200216. Epub 2011 Dec 20.
2
Blocking p38 signalling inhibits chondrogenesis in vitro but not ankylosis in a model of ankylosing spondylitis in vivo.阻断 p38 信号通路可抑制体外软骨生成,但不能抑制体内强直性脊柱炎模型中的骨融合。
Ann Rheum Dis. 2012 May;71(5):722-8. doi: 10.1136/annrheumdis-2011-200377. Epub 2011 Nov 25.
3
Osteoporosis: a paradox in ankylosing spondylitis.骨质疏松症:强直性脊柱炎的一个悖论。
Curr Osteoporos Rep. 2011 Sep;9(3):112-5. doi: 10.1007/s11914-011-0058-z.
4
Both structural damage and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitis.脊柱的结构损伤和炎症都会导致强直性脊柱炎患者的脊柱活动度受损。
Ann Rheum Dis. 2010 Aug;69(8):1465-70. doi: 10.1136/ard.2009.124206. Epub 2010 May 24.
5
Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis.硬化蛋白在强直性脊柱炎中的骨骼表达改变及其与影像学进展的关联。
Arthritis Rheum. 2009 Nov;60(11):3257-62. doi: 10.1002/art.24888.
6
Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years.评估使用阿达木单抗治疗长达2年的强直性脊柱炎患者脊柱的影像学进展情况。
Arthritis Res Ther. 2009;11(4):R127. doi: 10.1186/ar2794. Epub 2009 Aug 24.
7
Progress in spondylarthritis. Mechanisms of new bone formation in spondyloarthritis.脊柱关节炎的进展。脊柱关节炎中新骨形成的机制。
Arthritis Res Ther. 2009;11(2):221. doi: 10.1186/ar2642. Epub 2009 Apr 27.
8
Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a relationship between inflammation and new bone formation.脊柱磁共振成像上的炎性病变可预测强直性脊柱炎中新骨桥的形成:炎症与新骨形成之间关系的证据。
Arthritis Rheum. 2009 Jan;60(1):93-102. doi: 10.1002/art.24132.
9
BMP type I receptor inhibition reduces heterotopic [corrected] ossification.骨形态发生蛋白I型受体抑制可减少异位骨化。 (注:原文中“heterotopic [corrected] ossification”可能有误,推测应为“heterotopic ossification”,即异位骨化,这里按照推测后的正确内容进行了翻译)
Nat Med. 2008 Dec;14(12):1363-9. doi: 10.1038/nm.1888. Epub 2008 Nov 30.
10
Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis.强直性脊柱炎患者接受英夫利昔单抗治疗两年后的影像学表现。
Arthritis Rheum. 2008 Oct;58(10):3063-70. doi: 10.1002/art.23901.